Brazil Halts SinoVac COVID Vaccine Trial As China Lead Erodes
Plus: Clover Gets $328m In CEPI Funding
Executive Summary
China’s race to the coronavirus vaccine finish line has been dimmed by a new setback, although CanSino has commenced dosing of patients in Mexico and $328m in funding will help propel Clover's protein-based contender to the final stage.